E-Store

This assay is used to identify active uptake of a test compound by PepT1, using the Caco-2 cell monolayer system

EA224

This assay is used to detect glucuronidation of a test compound after incubation with human liver microsomes in the presence of UDPGA Required from Customer Either a minimum of 1.2 […]

EA433

This assay is used to develop dose vehicle(s) for a test compound, as a solution or suspension prior to in vivo pharmacokinetic testing

EA982

This assay is used to determine the unidirectional permeability (anterior-to-posterior) of a test compound through rabbit corneal or conjunctival tissue

EA226

This assay is used to determine the unidirectional permeability of a test compound through freshly excised porcine nasal epithelium

EA208

This assay is used to determine the unidirectional permeability of a test compound through freshly excised porcine buccal epithelium

EA207

This assay is used to determine the bidirectional permeability of a test compound through intestinal tissue segments (duodenum, ileum, jejunum and colon)

EA206

This assay is used to determine the unidirectional permeability of a test compound through intestinal tissue segments (duodenum, ileum, jejunum and colon)

EA205

This non-GLP assay is used to determine a preliminary BCS solubility classification by measuring the quasi-equilibrium solubility of a test compound in aqueous USP buffer systems at two pH values between 1.0 and 7.4

EA901

The hemolysis assay is used to determine the hemolytic effect of a test compound.

EA190

This assay is used to determine the bioavailability of a test compound in non-human primates (NHPs) when the compound is administered by at least two different routes.

EA806

This screening assay is used to determine the bioavailability/exposure of test compounds after two routes of administration to female rabbits.

EA821

This assay is used to determine the bioavailability / exposure of test compounds in male dogs after two routes of administration.

EA810

This assay is used to determine the bioavailability of a test compound in minipigs when the compound is administered by at least two different routes.

EA809

This screening assay is used to determine the bioavailability/exposure of test compounds after two routes of administration to male rats.

EA808